-
Electronic (PDF)
-
Site License
-
Enterprisewide
Lymphoblastic Lymphoma Global Clinical Trials Review, Q4, 2010
GlobalData, December 2010, Pages: 30
Lymphoblastic Lymphoma Global Clinical Trials Review, Q4, 2010
Summary
Our clinical trial report, “Lymphoblastic Lymphoma Global Clinical Trials Review, Q4, 2010" provides data on the Lymphoblastic Lymphoma clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Lymphoblastic Lymphoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Lymphoblastic Lymphoma).
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.
Scope
- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status and trial success rate
- Review of key discontinued trials (suspended, withdrawn and terminated)
- Overview of the enrollment pattern by phase for the past decade
- Number of clinical trials segmented by key drugs
- Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
- Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others
Reasons to buy
- Understand the dynamics of a particular indication as a whole
- Examine the performance of the trials in terms of their status, recruitment, success rates and others
- Obtain discontinued trial information for trials across the globe
- Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
List of Tables
List of Figures
Introduction
Lymphoblastic Lymphoma
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Countries Contributing to Clinical Trials in North America
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Lymphoblastic Lymphoma
Subjects Recruited Over a Period of Time
Prominent Sponsors
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Fred Hutchinson Cancer Research Center-Technology Transfer
Clinical Trial Overview of Fred Hutchinson Cancer Research Center-Technology Transfer
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
City of Hope National Medical Center
Clinical Trial Overview of City of Hope National Medical Center
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
The Vanderbilt-Ingram Cancer Center
Clinical Trial Overview of The Vanderbilt-Ingram Cancer Center
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Clinical Trial Overview of National Cancer Institute (NCI)
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About Us
Contact Us
Disclaimer
Source
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW6
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
